后疫情时代中国杭州诺如病毒的流行病学和遗传学特征

IF 4 3区 医学 Q2 VIROLOGY Journal of Clinical Virology Pub Date : 2024-04-23 DOI:10.1016/j.jcv.2024.105679
Danlei Chen , Qingyi Shao , Xuanwen Ru , Simiao Chen , Dongqing Cheng , Qing Ye
{"title":"后疫情时代中国杭州诺如病毒的流行病学和遗传学特征","authors":"Danlei Chen ,&nbsp;Qingyi Shao ,&nbsp;Xuanwen Ru ,&nbsp;Simiao Chen ,&nbsp;Dongqing Cheng ,&nbsp;Qing Ye","doi":"10.1016/j.jcv.2024.105679","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Norovirus (NoV) is an important human pathogen that can cause severe gastroenteritis in vulnerable populations. This study aimed to analyze the epidemiological and genetic characteristics of 2021–2023 NoV in Hangzhou, China.</p></div><div><h3>Methods</h3><p>This study enrolled patients aged 0–18 years who underwent NoV RNA detection in the hospital between January 2021 and October 2023 and analyzed the epidemiological characteristics of NoV. Polymerase chain reaction (PCR) was used to detect NoV RNA. Subtype classification and whole-genome sequencing were performed.</p></div><div><h3>Results</h3><p>There was a high prevalence of NoV infection in 2023, with NoV-positive samples accounting for 63.10 % of the total number of positive samples collected during the three-year period. The prevalence was abnormally high in summer, and the number of positive samples accounted for 48.20 % of the total positive samples for the whole year, which was much greater than the level in the same period in previous years (2023, 48.20% vs 2021, 13.66% vs 2022, 15.21 %). The GⅡ.4 subtype played a leading role, followed by increased mixed infection with GⅠ.5 and GⅡ.4. Whole-genome sequencing results suggested that GII.P16-GⅡ.4 had R297H and D372N key locus mutations. The evolutionary rate was 4.29 × 10<sup>−3</sup> for the RdRp gene and 4.84 × 10<sup>−3</sup> for the VP1 gene. The RdRp gene and VP1 gene of NoV GII.P16-GⅡ.4 have undergone rapid population evolution during the COVID-19 epidemic.</p></div><div><h3>Conclusion</h3><p>In the summer of 2023, an abnormally high incidence of NoV appeared in Hangzhou, China. The major epidemic strain GII.P16-GⅡ.4 showed a certain range of gene mutations and a fast evolutionary rate.</p></div>","PeriodicalId":15517,"journal":{"name":"Journal of Clinical Virology","volume":"172 ","pages":"Article 105679"},"PeriodicalIF":4.0000,"publicationDate":"2024-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Epidemiological and genetic characteristics of norovirus in Hangzhou, China, in the postepidemic era\",\"authors\":\"Danlei Chen ,&nbsp;Qingyi Shao ,&nbsp;Xuanwen Ru ,&nbsp;Simiao Chen ,&nbsp;Dongqing Cheng ,&nbsp;Qing Ye\",\"doi\":\"10.1016/j.jcv.2024.105679\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>Norovirus (NoV) is an important human pathogen that can cause severe gastroenteritis in vulnerable populations. This study aimed to analyze the epidemiological and genetic characteristics of 2021–2023 NoV in Hangzhou, China.</p></div><div><h3>Methods</h3><p>This study enrolled patients aged 0–18 years who underwent NoV RNA detection in the hospital between January 2021 and October 2023 and analyzed the epidemiological characteristics of NoV. Polymerase chain reaction (PCR) was used to detect NoV RNA. Subtype classification and whole-genome sequencing were performed.</p></div><div><h3>Results</h3><p>There was a high prevalence of NoV infection in 2023, with NoV-positive samples accounting for 63.10 % of the total number of positive samples collected during the three-year period. The prevalence was abnormally high in summer, and the number of positive samples accounted for 48.20 % of the total positive samples for the whole year, which was much greater than the level in the same period in previous years (2023, 48.20% vs 2021, 13.66% vs 2022, 15.21 %). The GⅡ.4 subtype played a leading role, followed by increased mixed infection with GⅠ.5 and GⅡ.4. Whole-genome sequencing results suggested that GII.P16-GⅡ.4 had R297H and D372N key locus mutations. The evolutionary rate was 4.29 × 10<sup>−3</sup> for the RdRp gene and 4.84 × 10<sup>−3</sup> for the VP1 gene. The RdRp gene and VP1 gene of NoV GII.P16-GⅡ.4 have undergone rapid population evolution during the COVID-19 epidemic.</p></div><div><h3>Conclusion</h3><p>In the summer of 2023, an abnormally high incidence of NoV appeared in Hangzhou, China. The major epidemic strain GII.P16-GⅡ.4 showed a certain range of gene mutations and a fast evolutionary rate.</p></div>\",\"PeriodicalId\":15517,\"journal\":{\"name\":\"Journal of Clinical Virology\",\"volume\":\"172 \",\"pages\":\"Article 105679\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2024-04-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Virology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1386653224000416\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"VIROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Virology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1386653224000416","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的诺罗病毒(NoV)是一种重要的人类病原体,可在易感人群中引起严重的肠胃炎。本研究旨在分析中国杭州 2021-2023 年 NoV 的流行病学和遗传学特征。方法本研究纳入了 2021 年 1 月至 2023 年 10 月期间在医院接受 NoV RNA 检测的 0-18 岁患者,并分析了 NoV 的流行病学特征。聚合酶链反应(PCR)用于检测NoV RNA。结果2023年NoV感染率较高,NoV阳性样本占三年期间采集的阳性样本总数的63.10%。夏季感染率异常高,阳性样本数占全年阳性样本总数的 48.20%,远高于往年同期水平(2023 年 48.20% vs 2021 年 13.66% vs 2022 年 15.21%)。其中,GⅡ.4亚型占主导地位,其次是GⅠ.5和GⅡ.4混合感染增多。全基因组测序结果表明,GⅡ.P16-GⅡ.4 有 R297H 和 D372N 关键位点突变。RdRp基因的进化速度为4.29×10-3,VP1基因的进化速度为4.84×10-3。NoV GII.P16-GⅡ.4的RdRp基因和VP1基因在COVID-19流行期间经历了快速的种群进化。主要流行株GII.P16-GⅡ.4出现了一定范围的基因突变,且进化速度较快。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Epidemiological and genetic characteristics of norovirus in Hangzhou, China, in the postepidemic era

Objective

Norovirus (NoV) is an important human pathogen that can cause severe gastroenteritis in vulnerable populations. This study aimed to analyze the epidemiological and genetic characteristics of 2021–2023 NoV in Hangzhou, China.

Methods

This study enrolled patients aged 0–18 years who underwent NoV RNA detection in the hospital between January 2021 and October 2023 and analyzed the epidemiological characteristics of NoV. Polymerase chain reaction (PCR) was used to detect NoV RNA. Subtype classification and whole-genome sequencing were performed.

Results

There was a high prevalence of NoV infection in 2023, with NoV-positive samples accounting for 63.10 % of the total number of positive samples collected during the three-year period. The prevalence was abnormally high in summer, and the number of positive samples accounted for 48.20 % of the total positive samples for the whole year, which was much greater than the level in the same period in previous years (2023, 48.20% vs 2021, 13.66% vs 2022, 15.21 %). The GⅡ.4 subtype played a leading role, followed by increased mixed infection with GⅠ.5 and GⅡ.4. Whole-genome sequencing results suggested that GII.P16-GⅡ.4 had R297H and D372N key locus mutations. The evolutionary rate was 4.29 × 10−3 for the RdRp gene and 4.84 × 10−3 for the VP1 gene. The RdRp gene and VP1 gene of NoV GII.P16-GⅡ.4 have undergone rapid population evolution during the COVID-19 epidemic.

Conclusion

In the summer of 2023, an abnormally high incidence of NoV appeared in Hangzhou, China. The major epidemic strain GII.P16-GⅡ.4 showed a certain range of gene mutations and a fast evolutionary rate.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Clinical Virology
Journal of Clinical Virology 医学-病毒学
CiteScore
22.70
自引率
1.10%
发文量
149
审稿时长
24 days
期刊介绍: The Journal of Clinical Virology, an esteemed international publication, serves as the official journal for both the Pan American Society for Clinical Virology and The European Society for Clinical Virology. Dedicated to advancing the understanding of human virology in clinical settings, the Journal of Clinical Virology focuses on disseminating research papers and reviews pertaining to the clinical aspects of virology. Its scope encompasses articles discussing diagnostic methodologies and virus-induced clinical conditions, with an emphasis on practicality and relevance to clinical practice. The journal publishes on topics that include: • new diagnostic technologies • nucleic acid amplification and serologic testing • targeted and metagenomic next-generation sequencing • emerging pandemic viral threats • respiratory viruses • transplant viruses • chronic viral infections • cancer-associated viruses • gastrointestinal viruses • central nervous system viruses • one health (excludes animal health)
期刊最新文献
Editorial Board Nucleic acid amplification testing using dried blood spots to confirm the diagnosis of HIV-1 in adults Quantification of human immunodeficiency virus type 2 (HIV-2) viral load in plasma: Comparison of three commercial assays Coinfections and iterative detection of respiratory viruses among 17,689 patients between March 2021 and December 2022 in Southern France Performance evaluation of the Abbott Alinity Hepatitis C antigen next assay in a US urban emergency department population
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1